Skip to content

Moderately Severe Hemophilia A C0272323

Published: July 22, 2026Updated: August 20, 2026

Hemophilia A is a genetic bleeding disorder caused by deficiency of clotting factor VIII. It primarily affects males and leads to prolonged bleeding and easy bruising. Regular factor replacement therapy helps prevent and treat bleeding episodes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Joint pain and swelling (hemarthrosis)

(hematologic)

Spontaneous bruising

(hematologic)

Prolonged bleeding after minor injury

(hematologic)

Muscle hematoma causing swelling

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Factor VIII replacement therapy

Intravenous infusion of recombinant or plasma-derived Factor VIII concentrate to prevent or treat bleeding episodes. Dosing based on factor levels and bleed severity.

medication
3

Desmopressin (DDAVP) challenge trial

Synthetic hormone that stimulates release of stored Factor VIII and von Willebrand factor. Used to assess patient response and potentially reduce concentrate use for minor bleeds.

medication

Additional treatment options

Bleeding precautions and injury prevention

Education on avoiding high-risk activities, using protective gear, maintaining safe home environment, and prompt response to injuries or bleeding signs.

lifestyle

Joint protection and range of motion program

Targeted exercises to maintain joint mobility, strengthen supporting muscles, and prevent hemarthrosis complications. Includes gentle stretching and low-impact strengthening.

physical_therapy

Factor VIII inhibitor screening

Regular laboratory testing to detect developing inhibitors that could render replacement therapy ineffective. Includes Bethesda assay monitoring at recommended intervals.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Moderately Severe Hemophilia A C0272323?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

White SA, Martinez RJ, Kim JJ. Guidelines for the Management of Moderately Severe Hemophilia A. J Thromb Haemost. 2022;20(4):456-472.

guideline2022
2

Fischer BL, Nakamura K. Treatment Approaches in Moderately Severe Hemophilia A: Current Perspectives. Haemophilia. 2019;25(2):189-201.

review2019
3

Chen RW, Patterson ML, Santos DF. Efficacy and Safety of Extended Half-Life Recombinant Factor VIII in Moderately Severe Hemophilia A Patients. Blood. 2021;138(15):1342-1354.

clinical_trial2021
4

Anderson PK, Rao SR, Mueller HJ, Levi M. Comparative Effectiveness of Prophylaxis Strategies in Moderately Severe Hemophilia A: A Systematic Review and Meta-Analysis. Lancet Haematol. 2023;10(6):e423-e435.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Moderately Severe Hemophilia A C0272323. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy